BGI, OpGen Collaborate on Use of Optical Mapping to Improve Sequence Finishing | GenomeWeb

By Julia Karow

This article has been updated from a previous version to include additional information from BGI and OpGen officials.

China's BGI and OpGen said last week that they are collaborating to use OpGen's optical mapping technology for de novo sequence finishing in human, plant, and animal genomes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.